(Q42547960)
Statements
1 reference
Optimization of 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines as potent, orally active CCK-A agonists (English)
1 reference
Henke BR
1 reference
Aquino CJ
1 reference
Birkemo LS
1 reference
Croom DK
1 reference
Dougherty RW Jr
1 reference
Ervin GN
1 reference
Grizzle MK
1 reference
Hirst GC
1 reference
James MK
1 reference
Johnson MF
1 reference
Queen KL
1 reference
Sherrill RG
1 reference
Sugg EE
1 reference
Suh EM
1 reference
Szewczyk JW
1 reference
Unwalla RJ
1 reference
Yingling J
1 reference
Willson TM
1 reference
1 August 1997
1 reference
1 reference
40
1 reference
17
1 reference
2706-2725
1 reference
Identifiers
1 reference
1 reference